Meeting
2023 ASCO Genitourinary Cancers Symposium
Cross-sectional study of patients' (pts) and physicians' needs and the financial toxicity of systemic treatment for metastatic renal cell carcinoma (mRCC) in Japan.
Authors
Takahiro Osawa
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Takahiro Osawa , Go Kimura , Yasuhisa Fujii , Yosuke Uchitomi , Kazunori Honda , Ariko Otani , Miki Kondo , Tetsuya Wako , Yoshihide Mitsuda , Daisuke Kawai , Michiko Sugawara , Hiromi Kitano , Nobuo Shinohara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 702)
DOI
10.1200/JCO.2023.41.6_suppl.702
Abstract #
702
Poster Bd #
J15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.
First Author: Shawna R Calhoun
Poster
2020 ASCO Virtual Scientific Program
Patient preferences and expectations of systemic therapy in renal cell carcinoma.
First Author: Dena Battle
Poster
2016 ASCO Quality Care Symposium
Preferred cost communicator and financial distress (FD) in patients with cancer.
First Author: Ellie Proussaloglou
Poster
2013 Genitourinary Cancers Symposium
Sequential use of targeted therapies for metastatic renal cell carcinoma: A physician survey and chart review of community oncology practices in the United States.
First Author: Nicholas J. Vogelzang